1. Home
  2. CSW vs CRSP Comparison

CSW vs CRSP Comparison

Compare CSW & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSW Industrials Inc.

CSW

CSW Industrials Inc.

N/A

Current Price

$296.37

Market Cap

5.2B

Sector

Industrials

ML Signal

N/A

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$53.58

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSW
CRSP
Founded
2014
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.8B
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
CSW
CRSP
Price
$296.37
$53.58
Analyst Decision
Hold
Buy
Analyst Count
5
17
Target Price
$323.20
$70.29
AVG Volume (30 Days)
100.5K
1.3M
Earning Date
05-21-2026
05-11-2026
Dividend Yield
0.38%
N/A
EPS Growth
N/A
N/A
EPS
3.04
N/A
Revenue
$1,082,549,000.00
$289,590,000.00
Revenue This Year
$23.19
$807.72
Revenue Next Year
$19.04
$172.52
P/E Ratio
$99.66
N/A
Revenue Growth
23.25
9169.85
52 Week Low
$230.45
$44.12
52 Week High
$355.48
$78.48

Technical Indicators

Market Signals
Indicator
CSW
CRSP
Relative Strength Index (RSI) 36.10 45.00
Support Level $286.82 $50.45
Resistance Level $306.59 $60.41
Average True Range (ATR) 9.70 2.49
MACD -4.25 -0.61
Stochastic Oscillator 1.51 11.17

Price Performance

Historical Comparison
CSW
CRSP

About CSW CSW Industrials Inc.

CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms & domain expertise across three segments: Contractor Solutions, Engineered Building Solutions, & Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient & performance-enhancing products for residential & commercial HVAC/R & plumbing applications, which are designed for professional end-use customers. The majority of the company's revenue is generated from the Contractor Solutions segment in the U.S. markets. products include mechanical products for heating, ventilation, air conditioning, & refrigeration, plumbing products, grilles, registers, & diffusers, building safety solutions, & high-performance specialty lubricants & sealants.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: